Man Group
IDYA icon

Man Group’s IDEAYA Biosciences IDYA Stock Holding History

Man Group’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.15M Buy
245,492
+73,646
+43% +$2.25M 0.01% 840
2026
Q1 		$5.73M Buy
171,846
+148,020
+621% +$4.97M 0.01% 1085
2025
Q4 		$824K Buy
23,826
+10,190
+75% +$325K ﹤0.01% 1736
2025
Q3 		$371K Sell
13,636
-54,407
-80% -$1.32M ﹤0.01% 1944
2025
Q2 		$1.43M Buy
68,043
+54,232
+393% +$1.04M ﹤0.01% 1525
2025
Q1 		$226K Buy
+13,811
New +$294K ﹤0.01% 2001

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Man Group's IDYA Position: Q2 2026 in Review

Man Group increased its IDEAYA Biosciences (IDYA) stake by 43% in Q2 2026, buying an estimated $2.25M and bringing the position to 245,492 shares worth $9.15M. The position accounts for 0.01% of the portfolio, ranked #840.

Man Group first reported a position in IDYA in Q1 2025 and has held it in 6 quarters since. 286 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Man Group held 245,492 shares of IDEAYA Biosciences worth $9.15M as of Q2 2026.
  • Man Group bought 73,646 IDEAYA Biosciences shares in Q2 2026, an estimated $2.25M.
  • IDEAYA Biosciences made up 0.01% of Man Group's portfolio in Q2 2026, its #840 holding.
  • Man Group first reported a position in IDEAYA Biosciences in Q1 2025 and has held it in 6 quarters since.
  • 286 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.